HC Wainwright & Co. Downgrades Biotricity to Neutral

Biotricity, Inc.

Biotricity, Inc.

BTCY

0.00

HC Wainwright & Co. analyst Kevin Dede downgrades Biotricity (NASDAQ: BTCY) from Buy to Neutral.